LEADER 03943nam 2200541 450 001 9910798170603321 005 20230808191805.0 010 $a0-309-37864-8 010 $a0-309-37862-1 035 $a(CKB)3710000000602661 035 $a(MiAaPQ)EBC4416302 035 $a(EXLCZ)993710000000602661 100 $a20170518h20162016 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aRapid medical countermeasure response to infectious diseases ? enabling sustainable capabilities through ongoing public- and private-sector partnerships $eworkshop summary /$fTheresa Wizemann, Megan Reeve Snair, and Jack Herrmann, rapporteurs 210 1$aWashington, District of Columbia :$cThe National Academies Press,$d2016. 210 4$dİ2016 215 $a1 online resource (177 pages) $cillustrations 311 $a0-309-37861-3 327 $aA wake-up call: the 2014 Ebola outbreak response -- Preparedness as an issue of national security -- Rapid development of Ebola vaccines -- Influenza risk assessment and pandemic preparedness -- Developing MCMs for coronaviruses -- Sustainable business models to ensure rapid and nimble responses -- Supporting MCM development across threats and funding cycles. 330 1 $a"Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since these diseases also know no boundaries and will easily cross borders. Sustaining public and private investment in the development of medical countermeasures (MCMs) before an emerging infectious disease becomes a public health emergency in the United States has been extremely challenging. Interest and momentum peak during a crisis and wane between events, and there is little interest in disease threats outside the United States until they impact people stateside. On March 26 and 27, 2015, the Institute of Medicine convened a workshop in Washington, DC to discuss how to achieve rapid and nimble MCM capability for new and emerging threats. Public- and private-sector stakeholders examined recent efforts to prepare for and respond to outbreaks of Ebola Virus Disease, pandemic influenza, and coronaviruses from policy, budget, and operational standpoints. Participants discussed the need for rapid access to MCM to ensure national security and considered strategies and business models that could enhance stakeholder interest and investment in sustainable response capabilities. This report summarizes the presentations and discussions from this workshop"--$cPublisher's description. 606 $aEmerging infectious diseases$xTreatment$vCongresses 606 $aDisaster medicine$vCongresses 606 $aMedical emergencies$vCongresses 606 $aPublic health$vCongresses 615 0$aEmerging infectious diseases$xTreatment 615 0$aDisaster medicine 615 0$aMedical emergencies 615 0$aPublic health 676 $a362.1969 700 $aWizemann$b Theresa M.$0890630 702 $aSnair$b Megan Reeve 702 $aHerrmann$b Jack 712 02$aInstitute of Medicine (U.S.).$bForum on Medical and Public Health Preparedness for Catastrophic Events. 712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation. 712 02$aInstitute of Medicine (U.S.).$bForum on Microbial Threats. 712 12$aEnabling Rapid Response and Sustained Capability with Medical Countermeasures to Mitigate Risk of Emerging Infectious Diseases (Workshop)$f(2015 :$eWashington, D.C.) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910798170603321 996 $aRapid medical countermeasure response to infectious diseases ? enabling sustainable capabilities through ongoing public- and private-sector partnerships$93854936 997 $aUNINA